Most just lately, it has been recognized that conolidine and the above mentioned derivatives act over the atypical chemokine receptor 3 (ACKR3. Expressed in equivalent regions as classical opioid receptors, it binds into a wide array of endogenous opioids. Unlike most opioid receptors, this receptor functions like a scavenger and doesn't activate a